Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

2. Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator

Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator 30354651 2018 10 25 1524-4539 138 17 2018 Oct 23 Circulation Circulation Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator. 1819-1827 10.1161/CIRCULATIONAHA.118.033505 Coronary artery calcium (CAC) is a powerful novel risk indicator for atherosclerotic cardiovascular

EvidenceUpdates2018

3. Calcium channel blockers are useful in managing Raynaud’s phenomenon

Calcium channel blockers are useful in managing Raynaud’s phenomenon Signal - Calcium channel blockers are useful in managing Raynaud’s phenomenon Dissemination Centre Discover Portal NIHR DC Discover Calcium channel blockers are useful in managing Raynaud’s phenomenon Published on 20 February 2018 Calcium channel blockers, such as nifedipine, are confirmed as useful in reducing the frequency, duration, severity of attacks, pain and disability associated with Raynaud’s phenomenon. People had (...) two to six fewer attacks per week on average with treatment, and 13 without. Raynaud’s is a disorder which reduces blood flow to the fingers and toes as a result of the blood vessels tightening and going into spasm in the cold. This updated review suggested that calcium channel blockers may be more effective in higher doses than lower doses and help primary symptoms rather than the secondary form of Raynaud’s that is due to underlying disease. Most research has been into nifedipine. Although

NIHR Dissemination Centre2018

4. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. BACKGROUND: Pre-eclampsia and eclampsia are common causes of serious morbidity and death. Calcium supplementation may reduce the risk of pre-eclampsia, and may help to prevent preterm birth. This is an update of a review last published in 2014. OBJECTIVES: To assess the effects of calcium supplementation during pregnancy on hypertensive disorders of pregnancy and related maternal and child (...) outcomes. SEARCH METHODS: We searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (18 September 2017), and reference lists of retrieved studies. SELECTION CRITERIA: We included randomised controlled trials (RCTs), including cluster-randomised trials, comparing high-dose calcium supplementation (at least 1 g daily of calcium) during pregnancy with placebo. For low-dose calcium we included quasi-randomised trials

Cochrane2018

6. Calcium

Calcium Top results for calcium - Trip Database or use your Google+ account Turning Research Into Practice My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for calcium The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory

Trip Latest and Greatest2018

7. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.

Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia. BACKGROUND: Beta thalassaemia is a common inherited blood disorder. The need for frequent blood transfusions in this condition poses a difficult problem to healthcare systems. The most common cause of morbidity and mortality is cardiac dysfunction from iron overload. The use of iron chelation therapy has reduced the severity of systemic iron overload but specific (...) , non-toxic treatment is required for removal of iron from the myocardium. OBJECTIVES: To assess the effects of calcium channel blockers combined with standard iron chelation therapy in people with transfusion-dependent beta thalassaemia on the amount of iron deposited in the myocardium, on parameters of heart function, and on the incidence of severe heart failure or arrhythmias and related morbidity and mortality. SEARCH METHODS: We searched the Cochrane Haemoglobinopathies Trials Register

Cochrane2018

8. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication

Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication Final Update Summary: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 3/6/2018 4:20:40 PM You are here: Final Summary Vitamin D, Calcium, or Combined (...) Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication Release Date: April 2018 Recommendation Summary Population Recommendation Grade Men and premenopausal women The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women. Postmenopausal women The USPSTF concludes

U.S. Preventive Services Task Force2018

9. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. Importance: Osteoporotic fractures result in significant morbidity and mortality. Objective: To update the evidence for benefits and harms of vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults to inform the US Preventive Services Task (...) Force. Data Sources: PubMed, EMBASE, Cochrane Library, and trial registries through March 21, 2017; references; and experts. Surveillance continued through February 28, 2018. Study Selection: English-language randomized clinical trials (RCTs) or observational studies of supplementation with vitamin D, calcium, or both among adult populations; studies of populations that were institutionalized or had known vitamin D deficiency, osteoporosis, or prior fracture were excluded. Data Extraction

JAMA2018

10. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement.

Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement. Importance: Because of the aging population, osteoporotic fractures are an increasingly important cause of morbidity and mortality in the United States. Approximately 2 million osteoporotic fractures occurred in the United States in 2005, and annual incidence is projected to increase to more than 3 million fractures (...) by 2025. Within 1 year of experiencing a hip fracture, many patients are unable to walk independently, more than half require assistance with activities of daily living, and 20% to 30% of patients will die. Objective: To update the 2013 US Preventive Services Task Force (USPSTF) recommendation on vitamin D supplementation, with or without calcium, to prevent fractures. Evidence Review: The USPSTF reviewed the evidence on vitamin D, calcium, and combined supplementation for the primary prevention

JAMA2018

11. Calcium channel blockers are useful in managing Raynaud’s phenomenon

Calcium channel blockers are useful in managing Raynaud’s phenomenon NIHR DC | Signal - Calcium channel blockers are useful in managing Raynaud’s phenomenon Dissemination Centre Discover Portal NIHR DC Discover Calcium channel blockers are useful in managing Raynaud’s phenomenon Published on 20 February 2018 Calcium channel blockers, such as nifedipine, are confirmed as useful in reducing the frequency, duration, severity of attacks, pain and disability associated with Raynaud’s phenomenon (...) . People had two to six fewer attacks per week on average with treatment, and 13 without. Raynaud’s is a disorder which reduces blood flow to the fingers and toes as a result of the blood vessels tightening and going into spasm in the cold. This updated review suggested that calcium channel blockers may be more effective in higher doses than lower doses and help primary symptoms rather than the secondary form of Raynaud’s that is due to underlying disease. Most research has been into nifedipine

NIHR Dissemination Centre2018

12. Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial

Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial 29496722 2018 03 02 1468-3288 2018 Mar 01 Gut Gut Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial. gutjnl-2017-315242 10.1136/gutjnl-2017-315242 Serrated lesions such as sessile serrated adenomas or polyps (SSA/Ps) are important colorectal cancer precursors, but aetiological factors for these lesions (...) are largely unknown. We aimed to determine the effects of calcium and vitamin D supplementation on the incidence of serrated polyps (SPs) in general and hyperplastic polyps and SSA/Ps specifically. Participants with one or more adenoma at baseline were randomised to receive 1200 mg/day of elemental calcium, 1000 IU/day of vitamin D 3 , both or neither agent. Treatment continued for 3 or 5 years, when risk of polyps was determined from surveillance colonoscopy (treatment phase). Outcomes after treatment

EvidenceUpdates2018

13. Calcium channel blockers for antipsychotic-induced tardive dyskinesia.

Calcium channel blockers for antipsychotic-induced tardive dyskinesia. BACKGROUND: Schizophrenia and related disorders affect a sizable proportion of any population. Antipsychotic medications are the primary treatment for these disorders. Antipsychotic medications are associated with a variety of adverse effects including tardive dyskinesia. Dyskinesia is a disfiguring movement disorder of the orofacial region that can be tardive (having a slow or belated onset). Tardive dyskinesia is difficult (...) to treat, despite experimentation with several treatments. Calcium channel blockers (diltiazem, nifedipine, nimodipine, verapamil, flunarizine) have been among these experimental treatments. OBJECTIVES: To determine the effects of calcium channel blocker drugs (diltiazem, nifedipine, nimodipine, verapamil) for treatment of neuroleptic-induced tardive dyskinesia in people with schizophrenia, schizoaffective disorder or other chronic mental illnesses. SEARCH METHODS: We searched the Cochrane

Cochrane2018

14. An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients

An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients | npj Breast Cancer Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure (...) continued support, we are displaying the site without styles and JavaScript. A Nature Research Journal An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients , , , , , , & npj Breast Cancer volume 4 , Article number: 6 ( 2018 ) | Subjects Abstract Neuronal calcium sensor-1 (NCS-1) has been identified as a binding partner of the taxane, paclitaxel. Our previous study showed that overexpression of NCS-1 increased the efficacy of paclitaxel in vitro

NPJ breast cancer2018 Full Text: Link to full Text with Trip Pro

15. Human cardiomyocyte calcium handling and transverse tubules in mid‐stage of post‐myocardial‐infarction heart failure

Human cardiomyocyte calcium handling and transverse tubules in mid‐stage of post‐myocardial‐infarction heart failure Human cardiomyocyte calcium handling and transverse tubules in mid-stage of post-myocardial- infarction heart failure Morten Andre Høydal 1,3 * , Idar Kirkeby-Garstad 2,3 , Asbjørn Karevold 2,3 , Rune Wiseth 2,3 , Rune Haaverstad 3 , Alexander Wahba 1,2,3 ,Tomas L. Stølen 1,3 , Riccardo Contu 4 , Gianluigi Condorelli 4 , Øyvind Ellingsen 1,2,3 , Godfrey L. Smith 2,5 , Ole J (...) , Carafoli E. Nature and site of phospho- lamban regulation of the Ca2+ pump of sarcoplasmic reticulum. Nature 1989; 342:90–92. 7. Gorski PA, Ceholski DK, Hajjar RJ. Al- teredmyocardialcalciumcyclinganden- ergetics in heart failure—a rational approach for disease treatment. Cell Metab 2015; 21:183–194. 8. Kho C, Lee A, Hajjar RJ. Altered sarco- plasmic reticulum calcium cycling—tar- gets for heart failure therapy. Nat Rev Cardiol 2012; 9:717–733. 9. BersDM. CardiacNa/Ca exchangefunc- tion in rabbit

ESC heart failure2018 Full Text: Link to full Text with Trip Pro

16. Calcium pyrophosphate deposition

Calcium pyrophosphate deposition Calcium pyrophosphate deposition - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Calcium pyrophosphate deposition Last reviewed: August 2018 Last updated: March 2018 Summary Calcium pyrophosphate arthritis is caused by deposition of calcium pyrophosphate (CPP) crystals. It can be difficult to diagnose as CPP crystals in synovial fluids can be small, sparse, and difficult to find (...) . In patients <60 years of age, underlying metabolic conditions associated with calcium pyrophosphate deposition (CPPD), such as hyperparathyroidism or haemochromatosis, should be investigated. There is no definitive treatment for CPP arthritis but intra-articular corticosteroids can be effective for both acute and chronic forms. Definition Calcium pyrophosphate deposition (CPPD) is associated with both acute and chronic arthritis. Acute CPP crystal arthritis is an acute inflammatory arthritis of one

BMJ Best Practice2018

17. Early marginal bone stability of dental implants placed in a transalveolarly augmented maxillary sinus: a controlled retrospective study of surface modification with calcium ions

Early marginal bone stability of dental implants placed in a transalveolarly augmented maxillary sinus: a controlled retrospective study of surface modification with calcium ions RESEARCH Open Access Early marginal bone stability of dental implants placed in a transalveolarly augmented maxillary sinus: a controlled retrospective study of surface modification with calcium ions Eduardo Anitua 1,2,3,5* , Laura Piñas 4 and Mohammad Hamdan Alkhraisat 2,3 Abstract Background: Recently, components (...) of the extracellular cellular matrix have been assessed to enhance the biological response to dental implants. This study aims to assess the effect of surface modification with calcium ions on the early marginal bone loss of dental implants placed in a transalveolarly augmented maxillary sinus. Methods: A retrospective study of transalveolar sinus floor augmentation was conducted in a single private dental clinic. The predictor variable was the surface of the dental implant. The primary outcome was the marginal

International journal of implant dentistry2017 Full Text: Link to full Text with Trip Pro

18. Calcium Tartrate Tetrahydrate, Case Report of a Novel Human Kidney Stone

Calcium Tartrate Tetrahydrate, Case Report of a Novel Human Kidney Stone Login to your account Username Password Keep me logged in Change Password Old Password New Password Too Short Weak Medium Strong Very Strong Too Long Congrats! Your password has been

Journal of endourology case reports2017 Full Text: Link to full Text with Trip Pro

19. Tobacco plants expressing the maize nitrate transporter ZmNrt2.1 exhibit altered responses of growth and gene expression to nitrate and calcium

Tobacco plants expressing the maize nitrate transporter ZmNrt2.1 exhibit altered responses of growth and gene expression to nitrate and calcium Ibrahim et al. Bot Stud (2017) 58:51 DOI 10.1186/s40529-017-0203-9 ORIGINAL ARTICLE Tobacco plants expressing the maize nitrate transporter ZmNrt2.1 exhibit altered responses of growth and gene expression to nitrate and calcium Abubakar Ibrahim 1,2 , Xiao-Lu Jin 1 , Yu-Bin Zhang 1,3 , Jessica Cruz 1 , Paveena Vichyavichien 1 , Nwadiuto Esiobu 1 and Xing (...) transporter ZmNrt2.1 gene that would bypass the tight control for the endogenous nitrate- responsive genes. By using calcium inhibitors and varying levels of NO 3 - , Ca 2+ and K + , we probed how the host plants were affected in their nitrate response. Results: We found that the ZmNrt2.1- expressing plants had better root growth than the wild type plants when Ca 2+ was deficient regardless of the nitrate levels. The growth restriction associated with Ca 2+ - deficiency can be alleviated with a high level

Botanical studies2017 Full Text: Link to full Text with Trip Pro

20. Collagen and Calcium Binding EGF Domains 1 (CCBE1) in cancer – a new role past lymphatics?

Collagen and Calcium Binding EGF Domains 1 (CCBE1) in cancer – a new role past lymphatics? 168 www.impactjournals.com/oncoscience Oncoscience www.impactjournals.com/oncoscience/ Oncoscience, Vol. 4(11-12), November 2017 Collagen and Calcium Binding EGF Domains 1 (CCBE1) in cancer – a new role past lymphatics? Aruz Mesci and Stanley K. Liu Genes that influence cancer behavior continue to be the focus of a plethora of research studies, with the hopes of either identifying biomarkers that help (...) predict/ prognosticate disease course, or discovering druggable targets for future therapies. Many of the gene products implicated in cancer also regulate normal developmental processes, hinting at the intimacy of the two processes. Collagen and Calcium Binding EGF Domains 1 (CCBE1) encodes a soluble protein with EGF-like domain and is located in human chromosomal region 18q21.32. Despite its original description as a gene frequently lost in breast cancer specimens [1], the earliest studies

Oncoscience2017 Full Text: Link to full Text with Trip Pro